AbbVie expands inflammatory disease pipeline with $250m Celsius acquisition
The deal includes an anti-TREM1 antibody that has completed a phase 1 study in inflammatory bowel disease
Read More
The deal includes an anti-TREM1 antibody that has completed a phase 1 study in inflammatory bowel disease
Read MoreJun 28, 2024 | News, Regulatory
More than 2,000 people in the UK are currently living with the genetic bleeding disorder
Read MoreJun 28, 2024 | News, Regulatory
The guidance will help to enhance the understanding of a disease or medical product being studied
Read MoreThe bridge RNA system allows researchers to edit, delete and convert DNA recombinases without using CRISPR
Read MoreApproximately 40% of people living with type 2 diabetes will develop CKD
Read MoreJun 27, 2024 | News, Regulatory
Approximately 15,000 people develop the form of non-Hodgkin lymphoma every year in the US
Read MoreJun 27, 2024 | News, Regulatory
More than 390 million people worldwide are living with COPD and about half of patients experience almost daily symptoms
Read MoreThe rare immunoglobulin-mediated autoimmune disease affects four in every 100,000 people annually
Read MoreAntimicrobial resistance has been declared by WHO as one of the top ten global public health threats
Read MoreMore than 614,000 new cases of the disease are diagnosed globally every year
Read MoreThe inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases
Read MorePanIN lesions can lead to invasive ductal adenocarcinoma, which affects nearly half a million people globally
Read MoreIntegrated Care Specialist - North & West Yorkshire
Territory Sales Manager - Yorkshire/North East
Territory Sales Manager - North London & East Anglia
Key Account Manager - Urology - East Anglia, Beds & Bucks
Territory Sales Manager - Ostomy Care - S Central/SW England